Cargando…

Chemical Degradation of Androgen Receptor (AR) Using Bicalutamide Analog–Thalidomide PROTACs

A series of PROTACs (PROteolysis-TArgeting Chimeras) consisting of bicalutamide analogs and thalidomides were designed, synthesized, and biologically evaluated as novel androgen receptor (AR) degraders. In particular, we found that PROTAC compound 13b could successfully demonstrate a targeted degrad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ga Yeong, Song, Chae Won, Yang, Yo-Sep, Lee, Na-Rae, Yoo, Hyung-Seok, Son, Seung Hwan, Lee, Soo Jin, Park, Jong Seon, Lee, Jong Kil, Inn, Kyung-Soo, Kim, Nam-Jung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123623/ https://www.ncbi.nlm.nih.gov/pubmed/33926033 http://dx.doi.org/10.3390/molecules26092525

Ejemplares similares

Efficacy of Bicalutamide 150-mg Monotherapy Compared With Combined Androgen Blockade in Patients With Locally Advanced Prostate Cancer
por: Kang, Yu Jin, et al.
Publicado: (2014)

Degrading AR-Dependent Cancers: Expanding the Role of PROTACs
por: Michmerhuizen, Anna R., et al.
Publicado: (2020)

Efficacy of Immediate Switching from Bicalutamide to Flutamide as Second-Line Combined Androgen Blockade
por: Yokomizo, Yumiko, et al.
Publicado: (2016)

Bicalutamide plus Aromatase Inhibitor in Patients with Estrogen Receptor‐Positive/Androgen Receptor‐Positive Advanced Breast Cancer
por: Lu, Qianyi, et al.
Publicado: (2019)

Thalidomide Inhibits Alternative Activation of Macrophages In Vivo and In Vitro: A Potential Mechanism of Anti-Asthmatic Effect of Thalidomide
por: Lee, Hyun Seung, et al.
Publicado: (2015)

A highly potent PROTAC androgen receptor (AR) degrader ARD-61 effectively inhibits AR-positive breast cancer cell growth in vitro and tumor growth in vivo
por: Zhao, Lijie, et al.
Publicado: (2020)

Charge density view on bicalutamide molecular interactions in the monoclinic polymorph and androgen receptor binding pocket
por: Korlyukov, Alexander A., et al.
Publicado: (2020)

Androgen receptor (AR) pathophysiological roles in androgen-related diseases in skin, bone/muscle, metabolic syndrome and neuron/immune systems: lessons learned from mice lacking AR in specific cells
por: Chang, Chawnshang, et al.
Publicado: (2013)

Spectrophotometric Estimation of Bicalutamide in Tablets
por: Sancheti, P. P., et al.
Publicado: (2008)

Chemical Knockdown of Phosphorylated p38 Mitogen-Activated Protein Kinase (MAPK) as a Novel Approach for the Treatment of Alzheimer′s Disease
por: Son, Seung Hwan, et al.
Publicado: (2023)

Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells
por: Kim, Young-Chae, et al.
Publicado: (2015)

Human Respiratory Syncytial Virus NS 1 Targets TRIM25 to Suppress RIG-I Ubiquitination and Subsequent RIG-I-Mediated Antiviral Signaling
por: Ban, Junsu, et al.
Publicado: (2018)

Synergic prodegradative activity of Bicalutamide and trehalose on the mutant androgen receptor responsible for spinal and bulbar muscular atrophy
por: Giorgetti, Elisa, et al.
Publicado: (2015)

Thalidomide for Treating Metastatic Hepatocellular Carcinoma: A Pilot Study
por: Han, Sang Hoon, et al.
Publicado: (2006)

A Study on the Resolution and Depth of Focus of ArF Immersion Photolithography
por: Song, Jungchul, et al.
Publicado: (2022)

Compression-Induced Phase Transitions of Bicalutamide
por: Szafraniec-Szczęsny, Joanna, et al.
Publicado: (2020)

Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments
por: Jung, Yoo Jin, et al.
Publicado: (2019)

PROTAC-DB: an online database of PROTACs
por: Weng, Gaoqi, et al.
Publicado: (2020)

The Immunomodulating Effects of Thalidomide and Dexamethasone in a Murine Cardiac Allograft Transplantation Model
por: Kim, Soo Jin, et al.
Publicado: (2022)

Regulation of MDA5-MAVS Antiviral Signaling Axis by TRIM25 through TRAF6-Mediated NF-κB Activation
por: Lee, Na-Rae, et al.
Publicado: (2015)

Bicalutamide, an androgen receptor antagonist, effectively alleviate allergic rhinitis via suppression of PI3K–PKB activity
por: Zhang, Yu, et al.
Publicado: (2022)

Activation of RIG-I-Mediated Antiviral Signaling Triggers Autophagy Through the MAVS-TRAF6-Beclin-1 Signaling Axis
por: Lee, Na-Rae, et al.
Publicado: (2018)

Synthesis and Biological Evaluation of O(6)-Aminoalkyl-Hispidol Analogs as Multifunctional Monoamine Oxidase-B Inhibitors towards Management of Neurodegenerative Diseases
por: Hassan, Ahmed H. E., et al.
Publicado: (2023)

Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs
por: Peach, Megan L., et al.
Publicado: (2020)

CCAR1 promotes chromatin loading of androgen receptor (AR) transcription complex by stabilizing the association between AR and GATA2
por: Seo, Woo-Young, et al.
Publicado: (2013)

Racial Differences in Androgen Receptor (AR) and AR Splice Variants (AR-SVs) Expression in Treatment-Naïve Androgen-Dependent Prostate Cancer
por: Khan, Farhan, et al.
Publicado: (2023)

Estrogen Receptor-α Targeting: PROTACs, SNIPERs, Peptide-PROTACs, Antibody Conjugated PROTACs and SNIPERs
por: Negi, Arvind, et al.
Publicado: (2022)

Systemic Immunomodulatory Effects of Combinatorial Treatment of Thalidomide and Dexamethasone on T Cells and Other Immune Cells
por: Kim, Eun Jee, et al.
Publicado: (2021)

Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system
por: Culig, Z, et al.
Publicado: (1999)

G protein-coupled estrogen receptor-1 agonist induces chemotherapeutic effect via ER stress signaling in gastric cancer
por: Lee, Seon-Jin, et al.
Publicado: (2019)

PROTAC-DB 2.0: an updated database of PROTACs
por: Weng, Gaoqi, et al.
Publicado: (2022)

Efficacy of abiraterone acetate for high-risk hormone-naïve metastatic prostate cancer: A comparison with combined androgen blockade therapy with bicalutamide and androgen deprivation therapy alone
por: Kanao, Kent, et al.
Publicado: (2022)

Diverse roles of androgen receptor (AR) domains in AR-mediated signaling
por: Claessens, Frank, et al.
Publicado: (2008)

Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer
por: Narayanan, Ramesh
Publicado: (2020)

Bicalutamide-induced hepatotoxicity: A rare adverse effect
por: Hussain, Salwa, et al.
Publicado: (2014)

Mesotherapy with Bicalutamide: A New Treatment for Androgenetic Alopecia
por: Gomez-Zubiaur, Alba, et al.
Publicado: (2023)

Renal Dysfunction and Tubulopathy Induced by High-Dose Tenofovir Disoproxil Fumarate in C57BL/6 Mice
por: Jang, Eungyeong, et al.
Publicado: (2020)

BK channel blocker paxilline attenuates thalidomide-caused synaptic and cognitive dysfunctions in mice
por: Choi, Tae-Yong, et al.
Publicado: (2018)

Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling
por: Lin, T-H, et al.
Publicado: (2013)

Design, synthesis, and biological evaluation of novel bioactive thalidomide analogs as anticancer immunomodulatory agents
por: Kotb, Anas Ramadan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bb7tqjkdh948gq6o603abt5m6c